Novavax Inc stated on Monday it has began the Part 1 scientific trial of a novel coronavirus vaccine candidate and has enrolled the trial’s first individuals, with preliminary outcomes slated for July.
Reuters brings you the most recent enterprise, finance and breaking information video from across the globe. Our fame for accuracy and impartiality is unparalleled.
Get the most recent information on:
Comply with Reuters on Fb:
Comply with Reuters on Twitter:
Comply with Reuters on Instagram: